In order to determine if monocytes inhibit the function of engineered T cells (as they do with natural T cells, through PD-L1/PD-1 signalling), human primary monocytes were used to mimic the hepatitis B virus (HBV)-related hepatocellular carcinoma tumour microenvironment (Fig. 3F).55 T cell cytotoxicity to HepG2 cancer spheroids was found to be impaired by monocytes for retrovirally transduced T cells only and not for mRNA electroporated T cells. The gene discussed is PDCD1; the disease is neoplasm.